Clinical Trial Update: A Study of BL-B01D1 in Patients With Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BL-B01D1 in recurrent glioblastoma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• BL-B01D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Recurrent Glioblastoma | Phase 2 | Status: RECRUITING